Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, Schmieder R, Joseph A, Rethemeier N, Nowack C, Bakris GL (2022)
Publication Type: Journal article
Publication year: 2022
Journal
Book Volume: 79
Pages Range: 2685-2695
Journal Issue: 12
DOI: 10.1161/HYPERTENSIONAHA.122.19744
Abstract
BACKGROUND: Chronic kidney disease is frequently associated with hypertension and poorly controlled blood pressure can lead to chronic kidney disease progression. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, significantly improves cardiorenal outcomes in patients with chronic kidney disease and type 2 diabetes. This analysis explored the relationship between office systolic blood pressure (SBP) and cardiorenal outcomes with finerenone in FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease).
Authors with CRIS profile
Involved external institutions
Research Institute Hospital 12 de Octubre (Imas12)
Spain (ES)
Richard L Roudebush VA Medical Center
United States (USA) (US)
Charité - Universitätsmedizin Berlin
Germany (DE)
National and Kapodistrian University of Athens
Greece (GR)
University of Michigan
United States (USA) (US)
Steno Diabetes Center
Denmark (DK)
Aristotle University of Thessaloniki
Greece (GR)
Bayer AG
Germany (DE)
University of Chicago Medical Center
United States (USA) (US)
Spain (ES)
Richard L Roudebush VA Medical Center
United States (USA) (US)
Charité - Universitätsmedizin Berlin
Germany (DE)
National and Kapodistrian University of Athens
Greece (GR)
University of Michigan
United States (USA) (US)
Steno Diabetes Center
Denmark (DK)
Aristotle University of Thessaloniki
Greece (GR)
Bayer AG
Germany (DE)
University of Chicago Medical Center
United States (USA) (US)
How to cite
APA:
Ruilope, L.M., Agarwal, R., Anker, S.D., Filippatos, G., Pitt, B., Rossing, P.,... Bakris, G.L. (2022). Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes. Hypertension, 79(12), 2685-2695. https://doi.org/10.1161/HYPERTENSIONAHA.122.19744
MLA:
Ruilope, Luis M., et al. "Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes." Hypertension 79.12 (2022): 2685-2695.
BibTeX: Download